These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 23086829)

  • 1. Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis.
    Kissow H; Hartmann B; Holst JJ; Poulsen SS
    Gut; 2013 Dec; 62(12):1724-33. PubMed ID: 23086829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous glucagon-like peptide- 1 and 2 are essential for regeneration after acute intestinal injury in mice.
    Hytting-Andreasen R; Balk-Møller E; Hartmann B; Pedersen J; Windeløv JA; Holst JJ; Kissow H
    PLoS One; 2018; 13(6):e0198046. PubMed ID: 29864142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestine.
    Kissow H; Viby NE; Hartmann B; Holst JJ; Timm M; Thim L; Poulsen SS
    Cancer Chemother Pharmacol; 2012 Jul; 70(1):39-48. PubMed ID: 22729158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis.
    Lee JM; Yoo IK; Lee JM; Kim SH; Choi HS; Kim ES; Keum B; Seo YS; Jeen YT; Chun HJ; Lee HS; Um SH; Kim CD
    BMC Cancer; 2019 Oct; 19(1):1016. PubMed ID: 31664952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide 2: a new treatment for chemotherapy-induced enteritis.
    Tavakkolizadeh A; Shen R; Abraham P; Kormi N; Seifert P; Edelman ER; Jacobs DO; Zinner MJ; Ashley SW; Whang EE
    J Surg Res; 2000 Jun; 91(1):77-82. PubMed ID: 10816354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptides 1 and 2: intestinal hormones implicated in the pathophysiology of mucositis.
    Kissow H
    Curr Opin Support Palliat Care; 2015 Jun; 9(2):196-202. PubMed ID: 25872118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice.
    Wu ZQ; Han XD; Wang Y; Yuan KL; Jin ZM; Di JZ; Yan J; Pan Y; Zhang P; Huang XY; Wang ZG; Zheng Q
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):87-96. PubMed ID: 20844880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.
    Soares PM; Lima-Junior RC; Mota JM; Justino PF; Brito GA; Ribeiro RA; Cunha FQ; Souza MH
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):713-20. PubMed ID: 21153821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alanyl-glutamine attenuates 5-fluorouracil-induced intestinal mucositis in apolipoprotein E-deficient mice.
    Araújo CV; Lazzarotto CR; Aquino CC; Figueiredo IL; Costa TB; Alves LA; Ribeiro RA; Bertolini LR; Lima AA; Brito GA; Oriá RB
    Braz J Med Biol Res; 2015 Jun; 48(6):493-501. PubMed ID: 25945744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis.
    Azevedo OG; Oliveira RA; Oliveira BC; Zaja-Milatovic S; Araújo CV; Wong DV; Costa TB; Lucena HB; Lima RC; Ribeiro RA; Warren CA; Lima AÂ; Vitek MP; Guerrant RL; Oriá RB
    BMC Gastroenterol; 2012 Jul; 12():35. PubMed ID: 22524518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human uridine phosphorylase-1 inhibitors: a new approach to ameliorate 5-fluorouracil-induced intestinal mucositis.
    Renck D; Santos AA; Machado P; Petersen GO; Lopes TG; Santos DS; Campos MM; Basso LA
    Invest New Drugs; 2014 Dec; 32(6):1301-7. PubMed ID: 25052233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Administration of Polaprezinc Attenuates Fluorouracil-induced Intestinal Mucositis in a Mouse Model.
    Liu Z; Xie W; Li M; Teng N; Liang X; Zhang Z; Yang Z; Wang X
    Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):480-486. PubMed ID: 28667794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide 2 improves intestinal wound healing through induction of epithelial cell migration in vitro-evidence for a TGF--beta-mediated effect.
    Bulut K; Meier JJ; Ansorge N; Felderbauer P; Schmitz F; Hoffmann P; Schmidt WE; Gallwitz B
    Regul Pept; 2004 Sep; 121(1-3):137-43. PubMed ID: 15256284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats.
    Cool JC; Dyer JL; Xian CJ; Butler RN; Geier MS; Howarth GS
    Growth Horm IGF Res; 2005 Feb; 15(1):72-82. PubMed ID: 15701575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of the NADPH oxidase NOX1 in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.
    Yasuda M; Kato S; Yamanaka N; Iimori M; Utsumi D; Kitahara Y; Iwata K; Matsuno K; Amagase K; Yabe-Nishimura C; Takeuchi K
    Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(10):G1133-42. PubMed ID: 22403796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.
    Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS
    Regul Pept; 2012 Nov; 179(1-3):91-100. PubMed ID: 22989472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis, Dysbiosis and Expression of Inflammatory Cytokines are Sequential Events in the Development of 5-Fluorouracil-Induced Intestinal Mucositis in Mice.
    Hamouda N; Sano T; Oikawa Y; Ozaki T; Shimakawa M; Matsumoto K; Amagase K; Higuchi K; Kato S
    Basic Clin Pharmacol Toxicol; 2017 Sep; 121(3):159-168. PubMed ID: 28374966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of Bu-Zhong-Yi-Qi decoction, the water extract of Chinese traditional herbal medicine, on 5-fluorouracil-induced intestinal mucositis in mice.
    Gou H; Gu LY; Shang BZ; Xiong Y; Wang C
    Hum Exp Toxicol; 2016 Dec; 35(12):1243-1251. PubMed ID: 26801985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rebamipide attenuates 5-Fluorouracil-induced small intestinal mucositis in a mouse model.
    Kim HJ; Kim JH; Moon W; Park J; Park SJ; Song GA; Han SH; Lee JH
    Biol Pharm Bull; 2015; 38(2):179-83. PubMed ID: 25747976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lyprinol only partially improves indicators of small intestinal integrity in a rat model of 5-fluorouracil-induced mucositis.
    Torres DM; Tooley KL; Butler RN; Smith CL; Geier MS; Howarth GS
    Cancer Biol Ther; 2008 Feb; 7(2):295-302. PubMed ID: 18059190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.